Johnson & Johnson to stop selling talc-based baby powder in US, Canada

Healthcare products and the talc-based powder will still be sold outside the US and Canada
Johnson & Johnson is ending sales of its iconic talc-based Johnson’s baby powder in the US and Canada, where demand has dwindled amid thousands of lawsuits claiming it has caused cancer. They said that healthcare products and the talc-based powder will still be sold outside the US and Canada.

 
“Demand for talc-based Johnson's Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising,” the company said.

 
J&J faces about 19,400 cases alleging its talcum powder caused users to develop ovarian cancer, through use for feminine hygiene, or mesothelioma, a cancer that strikes the lungs and other organs.

 
Of the cases that have been tried, J&J has had 12 wins, 15 losses and seven mistrials. All of the losses have either been overturned on appeal or are still being appealed.


Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel